Your Location:
Home >
Browse articles >
Tongxinluo Ameliorates Myocardial Ischemia-Reperfusion Injury Mainly via Activating Parkin-Mediated Mitophagy and Downregulating Ubiquitin-Proteasome System*
Original Article | Updated:2021-09-01
    • Tongxinluo Ameliorates Myocardial Ischemia-Reperfusion Injury Mainly via Activating Parkin-Mediated Mitophagy and Downregulating Ubiquitin-Proteasome System*

    • Tongxinluo Ameliorates Myocardial Ischemia-Reperfusion Injury Mainly via Activating Parkin-Mediated Mitophagy and Downregulating Ubiquitin-Proteasome System*

    • Chinese Journal of Integrative Medicine   2021年27卷第7期 页码:542-550
    • DOI:10.1007/s11655-019-3166-8    

      中图分类号:
    • 纸质出版日期:2021-07-01

      网络出版日期:2019-06-21

      录用日期:2019-05-14

    Scan for full text

  • Hong-xing YANG, Peng WANG, Ning-ning WANG, 等. Tongxinluo Ameliorates Myocardial Ischemia-Reperfusion Injury Mainly via Activating Parkin-Mediated Mitophagy and Downregulating Ubiquitin-Proteasome System*[J]. Chinese Journal of Integrative Medicine, 2021,27(7):542-550. DOI: 10.1007/s11655-019-3166-8.

    Hong-xing YANG, Peng WANG, Ning-ning WANG, et al. Tongxinluo Ameliorates Myocardial Ischemia-Reperfusion Injury Mainly via Activating Parkin-Mediated Mitophagy and Downregulating Ubiquitin-Proteasome System*[J]. Chinese Journal of Integrative Medicine, 2021,27(7):542-550. DOI: 10.1007/s11655-019-3166-8.

  •  
  •  
More>

0

浏览量

0

Downloads

2

CSCD

文章被引用时,请邮件提醒。
Submit
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

Role of Mitophagy in Myocardial Ischemia/Reperfusion Injury and Chinese Medicine Treatment
Protective Effects and Mechanisms of Shenhua Tablet (肾华片) on Toll-Like Receptors in Rat Model of Renal Ischemia-Reperfusion Injury
Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini
Immunomodulatory Function of Pien Tze Huang in T Cell-Mediated Anti-tumor Activity against B16-F10, MC38 and Hep1-6 Tumor Models
Safflower Yellow Inhibits Progression of Hepatocellular Carcinoma by Modulating Immunological Tolerance via FAK Pathway

相关作者

暂无数据

相关机构

Department of Cardiology, Dongfang Hospital, the Second Affiliated Hospital of Beijing University of Chinese Medicine
Department of Cardiology,Dongzhimen Hospital, the First Affiliated Hospital of Beijing University of Chinese Medicine
Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research
Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine
State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Science, Xiamen University
0